Document Type : Original Article
Authors
1
PhD student in International Law, Faculty of Law and Political Sciences, Islamic Azad University, Karaj Branch, Karaj, Iran
2
Assistant Professor of International Law, Faculty of Law and Political Science, Islamic Azad University, Karaj, Iran.
3
Assistant Professor of Law, Faculty of Law and Political Science, Islamic Azad University, Karaj, Iran
10.48308/jlr.2023.230122.2423
Abstract
In the ecosystem of the health system, ensuring quality control, safety and effectiveness of drugs is very sensitive and necessary for people's health. After the Covid-19 pandemic, fake vaccine drugs have been circulating and seriously threatening public health around the world. This situation needs to pay more attention to the quality and more effective safety of medicine with the aim of combating drug counterfeiting. The current measures are not effective and sufficient to deal with all the problems associated with counterfeit drugs. In this article, by examining the importance of drug safety monitoring, it was observed that developing countries do not have adequate, standardized and integrated international monitoring regulations to evaluate the quality and safety of drugs. Finally, due to the lack of control over the supply chain, drugs will easily enter the flow of forgery and fraud. The existence of strong monitoring institutions in accordance with the standards of national or international laws, as well as the application of deterrent punishments in each of the stages of the drug production, distribution and delivery cycle, is required. This research is based on an analytical-descriptive method and on the basis of authentic library documents and sources. The theoretical framework of the research is rights based on justice.
Keywords
Main Subjects
)